b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">30103189</PMID>\n        <DateCompleted>\n            <Year>2018</Year>\n            <Month>10</Month>\n            <Day>22</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2018</Year>\n            <Month>11</Month>\n            <Day>02</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1768-3254</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>157</Volume>\n                    <PubDate>\n                        <Year>2018</Year>\n                        <Month>Sep</Month>\n                        <Day>05</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>European journal of medicinal chemistry</Title>\n                <ISOAbbreviation>Eur J Med Chem</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Pyridine bioisosteres of potent GluN2B subunit containing NMDA receptor antagonists with benzo[7]annulene scaffold.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>397-404</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S0223-5234(18)30658-5</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejmech.2018.08.003</ELocationID>\n            <Abstract>\n                <AbstractText>It has been reported that benzo [7]annulen-7-amines bearing electron withdrawing substituents such as 3d with a 2-Cl or 3e with a 2-NO<sub>2</sub> moiety show very high affinity towards the ifenprodil binding site of GluN2B subunit containing NMDA receptors. Therefore, bioisosteres of 3 with an electron deficient pyridine ring instead of the chloro- or nitrobenzene ring were envisaged. Starting from pyridine-2,3-dicarboxylic acid (5) a five-step synthesis of the key intermediate, the ketone 10, was developed. Reductive amination with various primary amines and NaBH(OAc)<sub>3</sub> led to the homologous secondary amines 11a-c. Subsequent methylation yielded the tertiary amines 12b and 12c. Receptor binding studies with [<sup>3</sup>H]ifenprodil revealed K<sub>i</sub>-values above 100\xe2\x80\xafnM for the most active phenylpropyl- and phenylbutylamines 11b and 11c. The &gt;100-fold reduced GluN2B affinity of pyridines 11b and 11c compared to the GluN2B affinity of the corresponding chloro- and nitrobenzene derivatives 3d and 3e indicates that the pyridine ring is not tolerated as bioisosteric replacement of the chloro- or nitrobenzene ring in this type of compounds.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2018 Elsevier Masson SAS. All rights reserved.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Zscherp</LastName>\n                    <ForeName>Robert</ForeName>\n                    <Initials>R</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Institut f\xc3\xbcr Pharmazeutische und Medizinische Chemie der Westf\xc3\xa4lischen Wilhelms-Universit\xc3\xa4t M\xc3\xbcnster, Corrensstra\xc3\x9fe 48, D-48149, M\xc3\xbcnster, Germany.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Baumeister</LastName>\n                    <ForeName>S\xc3\xb6ren</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Institut f\xc3\xbcr Pharmazeutische und Medizinische Chemie der Westf\xc3\xa4lischen Wilhelms-Universit\xc3\xa4t M\xc3\xbcnster, Corrensstra\xc3\x9fe 48, D-48149, M\xc3\xbcnster, Germany.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Schepmann</LastName>\n                    <ForeName>Dirk</ForeName>\n                    <Initials>D</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Institut f\xc3\xbcr Pharmazeutische und Medizinische Chemie der Westf\xc3\xa4lischen Wilhelms-Universit\xc3\xa4t M\xc3\xbcnster, Corrensstra\xc3\x9fe 48, D-48149, M\xc3\xbcnster, Germany.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>W\xc3\xbcnsch</LastName>\n                    <ForeName>Bernhard</ForeName>\n                    <Initials>B</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Institut f\xc3\xbcr Pharmazeutische und Medizinische Chemie der Westf\xc3\xa4lischen Wilhelms-Universit\xc3\xa4t M\xc3\xbcnster, Corrensstra\xc3\x9fe 48, D-48149, M\xc3\xbcnster, Germany; Cells-in-Motion Cluster of Excellence (EXC 1003 - CiM), Westf\xc3\xa4lische Wilhelms-Universit\xc3\xa4t M\xc3\xbcnster, Germany. Electronic address: wuensch@uni-muenster.de.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>08</Month>\n                <Day>04</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>France</Country>\n            <MedlineTA>Eur J Med Chem</MedlineTA>\n            <NlmUniqueID>0420510</NlmUniqueID>\n            <ISSNLinking>0223-5234</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000588">Amines</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C121001">NR2B NMDA receptor</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D011083">Polycyclic Compounds</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D011725">Pyridines</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D016194">Receptors, N-Methyl-D-Aspartate</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C000628676">benzo (7)annulen-7-amine</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>NH9L3PP67S</RegistryNumber>\n                <NameOfSubstance UI="C023666">pyridine</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000588" MajorTopicYN="N">Amines</DescriptorName>\n                <QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName>\n                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>\n                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006168" MajorTopicYN="N">Guinea Pigs</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015394" MajorTopicYN="N">Molecular Structure</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011083" MajorTopicYN="N">Polycyclic Compounds</DescriptorName>\n                <QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName>\n                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>\n                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011725" MajorTopicYN="N">Pyridines</DescriptorName>\n                <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>\n                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016194" MajorTopicYN="N">Receptors, N-Methyl-D-Aspartate</DescriptorName>\n                <QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D013329" MajorTopicYN="N">Structure-Activity Relationship</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Affinity</Keyword>\n            <Keyword MajorTopicYN="N">GluN2B antagonists</Keyword>\n            <Keyword MajorTopicYN="N">Ifenprodil binding site</Keyword>\n            <Keyword MajorTopicYN="N">NMDA receptor</Keyword>\n            <Keyword MajorTopicYN="N">Pyridine-benzene bioisosteres</Keyword>\n            <Keyword MajorTopicYN="N">Selectivity</Keyword>\n            <Keyword MajorTopicYN="N">Structure-affinity relationships</Keyword>\n            <Keyword MajorTopicYN="N">[7]annuleno[b]pyridin-7-amines</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>04</Month>\n                <Day>26</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2018</Year>\n                <Month>05</Month>\n                <Day>22</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>08</Month>\n                <Day>01</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>8</Month>\n                <Day>14</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>23</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>8</Month>\n                <Day>14</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30103189</ArticleId>\n            <ArticleId IdType="pii">S0223-5234(18)30658-5</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.ejmech.2018.08.003</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'